This study is in progress, not accepting new patients
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
Summary
- Eligibility
- for females ages 18 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCSD
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- Links
- Gilead Clinical Trials Website
- ID
- NCT06101329
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 253 people participating
- Last Updated